CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $91,671,669
- in 32 filings, $73.3M under 10b5-1 plans
Net −$91,671,669. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Leproust Emily M. −$76.4M Chief Executive Officer sold 43% of stake
- Finn Patrick John −$6.8M President and COO sold 16% of stake
- Green Paula −$2.6M SVP of Human Resources sold 23% of stake
- Cho Dennis −$2.6M Reporting owner sold 17% of stake
- Laponis Adam −$2.6M Chief Financial Officer sold 12% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | THORBURN JAMES M Chief Financial Officer | Shares withheld for taxes | −382 | $36.86 | $14K | 86,334 |
| 2023-12-19 | THORBURN JAMES M Chief Financial Officer | Shares withheld for taxes | −544 | $38.33 | $21K | 86,716 |
| 2023-11-20 | THORBURN JAMES M Chief Financial Officer | Shares withheld for taxes | −1,028 | $24.74 | $25K | 87,260 |
| 2023-11-02 | THORBURN JAMES M Chief Financial Officer | Grant or award | +19,769 | 78,371 | ||
| 2023-11-02 | THORBURN JAMES M Chief Financial Officer | Shares withheld for taxes | −4,164 | $17.31 | $72K | 74,207 |
| 2023-11-02 | THORBURN JAMES M Chief Financial Officer | Grant or award | +14,081 | 88,288 | ||
| 2023-10-24 | THORBURN JAMES M Chief Financial Officer | Shares withheld for taxes | −275 | $16.58 | $5K | 58,602 |
Page 1 of 1 · 7 trades